MDT

88.44

-1.53%↓

VEEV

227.74

-1.64%↓

A

113.65

-2.76%↓

HQY

87.08

-1.46%↓

PDCO

31.26

0%↓

MDT

88.44

-1.53%↓

VEEV

227.74

-1.64%↓

A

113.65

-2.76%↓

HQY

87.08

-1.46%↓

PDCO

31.26

0%↓

MDT

88.44

-1.53%↓

VEEV

227.74

-1.64%↓

A

113.65

-2.76%↓

HQY

87.08

-1.46%↓

PDCO

31.26

0%↓

MDT

88.44

-1.53%↓

VEEV

227.74

-1.64%↓

A

113.65

-2.76%↓

HQY

87.08

-1.46%↓

PDCO

31.26

0%↓

MDT

88.44

-1.53%↓

VEEV

227.74

-1.64%↓

A

113.65

-2.76%↓

HQY

87.08

-1.46%↓

PDCO

31.26

0%↓

Search

Stryker Corp

Uždarymo kaina

SektoriusSveikatos priežiūra

373.03 0.21

Apžvalga

Akcijų kainos pasikeitimas

24 val.

Dabar

Min

366.01

Max

373.77

Pagrindiniai rodikliai

By Trading Economics

Pajamos

-288M

546M

Pardavimai

946M

6.4B

P/E

Sektoriaus vid.

48.094

63.778

Pelnas, tenkantis vienai akcijai

4.01

Dividendų pajamingumas

0.9

Pelno marža

8.484

Darbuotojai

53,000

EBITDA

385M

1.8B

Rekomendacijos

By TipRanks

Rekomendacijos

Stiprus pirkimas

12 mėnesių prognozė

+16.61% upside

Dividendai

By Dow Jones

Dividendų pajamingumas

Sektoriaus vid.

0.90%

2.39%

Kitas uždarbis

2025-04-29

Kitas dividendų mokėjimo data

2025-04-30

Rinkos statistika

By TradingEconomics

Rinkos kapitalizacija

-8.2B

142B

Ankstesnė atidarymo kaina

372.82

Ankstesnė uždarymo kaina

373.03

Naujienos nuotaikos

By Acuity

44%

56%

150 / 386 reitingas Healthcare

Techninis įvertinimas

By Trading Central

Pasitikėjimas

Bullish Evidence

Stryker Corp Grafikas

Ankstesni rezultatai nėra patikimas būsimų rezultatų rodiklis.

Susijusios naujienos

2025-01-28 21:55; UTC

Uždarbis

Stryker Sees Further Organic Sales Growth in 2025

2025-01-28 21:46; UTC

Įsigijimai, susijungimai, perėmimai

Stryker to Sell Spinal Implants Business to Viscogliosi Brothers

2025-01-06 22:18; UTC

Įsigijimai, susijungimai, perėmimai

Stryker to Acquire Inari Medical in Deal Valued at $4.9 Billion -- Update

2025-01-06 21:39; UTC

Įsigijimai, susijungimai, perėmimai

Stryker to Acquire Inari Medical in Deal Valued at $4.9 Billion

2025-02-19 13:53; UTC

Įsigijimai, susijungimai, perėmimai

Stryker Files 8K - Asset Acquisition Or Disposition >SYK

2025-02-19 13:30; UTC

Įsigijimai, susijungimai, perėmimai

Stryker Completes Acquisition Of Inari Medical, Inc., Providing Entry Into The High-growth Peripheral Vascular Segment >SYK

2025-01-28 21:09; UTC

Įsigijimai, susijungimai, perėmimai

Stryker: Transaction Is Expected to Close in the U.S. in 1H 2025 >SYK

2025-01-28 21:09; UTC

Įsigijimai, susijungimai, perėmimai

Stryker: Agreement Includes Binding Offer to Acquire Stryker's Spinal Implants Business in France >SYK

2025-01-28 21:08; UTC

Įsigijimai, susijungimai, perėmimai

Stryker: After Closing, VB Spine Will Become a Strategic Partner to Stryker With Exclusive Access to Mako Spine and Copilot for Use With VB Spine's Implants in Spine Procedures >SYK

2025-01-28 21:08; UTC

Įsigijimai, susijungimai, perėmimai

Stryker: Agreement to Sell U.S. Spinal Implants Business to Viscogliosi Brothers, LLC to Create Newly Formed Co Called VB Spine, LLC >SYK

2025-01-28 21:06; UTC

Uždarbis

Stryker Sees Organic Net Sales Growth of 8% to 9% for 2025 >SYK

2025-01-28 21:06; UTC

Uždarbis

Stryker Sees FY Adj EPS $13.45-Adj EPS $13.70 >SYK

2025-01-28 21:05; UTC

Įsigijimai, susijungimai, perėmimai

Stryker: Announces Definitive Agreement for the Sale of U.S. Spinal Implants Business and Plans to Sell Related Intl Business

2025-01-28 21:05; UTC

Uždarbis

Stryker 4Q Net $500M >SYK

2025-01-28 21:05; UTC

Uždarbis

Stryker 4Q Adj EPS $4.01 >SYK

2025-01-28 21:05; UTC

Uždarbis

Stryker 4Q Net $546M >SYK

2025-01-28 21:05; UTC

Uždarbis

Stryker 4Q Net $500M >SYK

2025-01-28 21:05; UTC

Uždarbis

Stryker 4Q Sales $6.4B >SYK

2025-01-28 21:05; UTC

Uždarbis

Stryker 4Q EPS $1.41 >SYK

2025-01-28 21:05; UTC

Uždarbis

Stryker 4Q Adj EPS $4.01 >SYK

2025-01-28 21:05; UTC

Uždarbis

Stryker 4Q EPS $1.41 >SYK

2025-01-28 21:05; UTC

Uždarbis

Stryker 4Q Sales $6.4B >SYK

2025-01-17 21:20; UTC

Įsigijimai, susijungimai, perėmimai

Stryker Commences Tender Offer for All Outstanding Shrs of Common Stock of Inari Medical

2025-01-13 19:30; UTC

Uždarbis

Update: Stryker Had A Good Year Last Year; Here's How It's Looking For 2025 -- IBD

2025-01-07 09:58; UTC

Karštos akcijos

Stocks to Watch Tuesday: Nvidia, Uber, Tencent -- WSJ

2025-01-06 22:03; UTC

Svarbiausios naujienos
Įsigijimai, susijungimai, perėmimai

Stryker to Acquire Inari Medical in Deal Valued at $4.9B -- Update

2025-01-06 21:49; UTC

Įsigijimai, susijungimai, perėmimai

Inari Medical Catapults -- Again -- After Stryker Confirms $4.9 Billion Deal -- IBD

2025-01-06 21:24; UTC

Svarbiausios naujienos
Įsigijimai, susijungimai, perėmimai

Stryker to Acquire Inari Medical in Deal Valued at $4.9B

2025-01-06 21:11; UTC

Įsigijimai, susijungimai, perėmimai

Stryker: Inari's Innovative Pdt Portfolio Is Highly Complementary to Our Neurovascular Business >SYK

2025-01-06 21:10; UTC

Įsigijimai, susijungimai, perėmimai

Stryker: Transaction Is Anticipated to Close by the End of the 1Q >SYK

Akcijų palyginimas

Kainos pokytis

Stryker Corp Prognozė

Kainos tikslas

By TipRanks

16.61% į viršų

12 mėnesių prognozė

Vidutinis 435.3 USD  16.61%

Aukščiausias 465 USD

Žemiausias 400 USD

Remiantis 22 „Wall Street“ analitikais, siūlančiais 12 mėnesių tikslines Stryker Corp kainas – Dist per pastaruosius 3 mėnesius.

Bendras įvertinimas

By TipRanks

Stiprus pirkimas

22 ratings

18

Pirkti

4

Laikyti

0

Parduoti

Techninis įvertinimas

By Trading Central

372.77 / 374.61Palaikymas ir pasipriešinimas

Trumpalaikis periodas

Bullish Evidence

Vidutinės trukmės periodas

Bearish Evidence

Ilgalaikis periodas

Neutral Evidence

Rinkos nuotaikos

By Acuity

150 / 386 reitingas Sveikatos priežiūra

Naujienos nuotaikos

Bulių rinkos įrodymas

Svyravimai

Žemiau vidurkio

Naujienų apimtis (RCV)

Aukščiau vidurkio

Finansinės naujienos

Pardavimo ir administravimo išlaidos

Veiklos sąnaudos

Ikimokestinis pelnas

Pardavimai

Pardavimo savikaina

Bendrasis pelnas iš pardavimo

Skolų palūkanų išlaidos

EBITDA

Veiklos pelnas

$

Apie bendrovę Stryker Corp

Stryker Corporation operates as a medical technology company. The company operates through two segments, MedSurg and Neurotechnology, and Orthopaedics and Spine. The Orthopaedics and Spine segment provides implants for use in total joint replacements, such as hip, knee and shoulder, and trauma and extremities surgeries. This segment also offers spinal implant products comprising cervical and thoracolumbar systems that include fixation, minimally invasive and interbody systems used in spinal injury, complex spine and degenerative therapies. The MedSurg and Neurotechnology segment offers surgical equipment, and surgical navigation systems, endoscopic and communications systems, patient handling, emergency medical equipment and intensive care disposable products, reprocessed and remanufactured medical devices, clinical communication and workflow solutions, and other medical device products that are used in various medical specialties, as well as patient and caregiver safety technologies. This segment also provides neurosurgical, neurovascular and craniomaxillofacial implant products, which include products used for minimally invasive endovascular procedures; products for brain and open skull based surgical procedures; orthobiologic and biosurgery products, such as synthetic bone grafts and vertebral augmentation products; minimally invasive products for the treatment of acute ischemic and hemorrhagic stroke; and craniomaxillofacial implant products, including cranial, maxillofacial, and chest wall devices, as well as dural substitutes and sealants. The company sells its products to doctors, hospitals, and other healthcare facilities through company-owned subsidiaries and branches, as well as third-party dealers and distributors in approximately 75 countries. Stryker Corporation was founded in 1941 and is headquartered in Portage, Michigan.